Wheeler CJ, Black KL, Liu G, Mazer M, Zhang XX, Pepkowitz S, Goldfinger D, Ng H, Irvin D, Yu JS. Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients. Cancer Res. 2008;68(14):5955–5964.

Ghods AJ, Irvin D, Liu G, Yuan X, Abdulkadir IR, Tunici P, Konda B, Wachsmann-Hogiu S, Black KL, Yu JS. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells. 2007;25(7):1645–1653.

Zeng Z, Yuan X, Liu G, Zeng Xianhao, Zeng Xiaorong, Ng H, Chen H, Jiang T, Akasaki Y, Kessey K, Black KL, Yu JS. Manipulation of proliferation and differentiation of human bone marrow–derived neural stem cells in vitro and in vivo. J Neurosci Res. 2007;85(2):310–320.

Hu J, Yuan X, Belladonna ML, Ong JM, Wachsmann-Hogiu S, Farkas DL, Black KL, Yu JS. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Cancer Res. 2006;66(17):8887–8896.

Yuan X, Hu J, Belladonna ML, Black KL, Yu JS. Interleukin-23-expressing bone marrow–derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res. 2006;66(5):2630-2638.

Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells. 2009;27(8):1734-1740.

Milanesi A, Lee J-W, Li Z, Da Sacco S, Villani V, Cervantes V, Perin L, Yu JS. β-cell regeneration mediated by human bone marrow mesenchymal stem cells. PLoS ONE. 2012;7(8):e42177.

Lee BS, Amano T, Wang HQ, Pantoja JL, Yoon CW, Hanson, CJ, Amatya R, Yen A, Black KL, Yu JS. Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastoma. ACS Nano [in press, 2013].

Ji J et al. Identification of novel HLA-A0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy. Stem Cells Transl Med [in press].